Related Experiment Video
Updated: Feb 3, 2026

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
Published on: September 26, 2012
Recent advances in the pathogenesis of BPD
1Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Giessen, Germany.
Bronchopulmonary dysplasia (BPD) impairs newborn lung development, particularly alveolarization, in preterm infants. Recent research explores growth factors, oxidative stress, and cell plasticity to understand and model BPD's complex pathomechanisms.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Developmental Biology
Background:
- Bronchopulmonary dysplasia (BPD) is a common complication of preterm birth, characterized by impaired lung alveolarization.
- Infants born extremely preterm are at high risk for BPD, necessitating deeper understanding of its underlying mechanisms.
Purpose of the Study:
- To review recent advancements in understanding the pathomechanisms of stunted lung development in BPD.
- To discuss current challenges and new developments in modeling BPD.
Main Methods:
- Literature review of recent research on BPD pathomechanisms.
- Examination of studies on growth factor signaling, oxidative stress, inflammation, extracellular matrix, non-coding RNA, and cell plasticity.
- Analysis of experimental animal and in vitro models for BPD.
Main Results:
- Recent studies highlight roles for growth factor signaling, oxidative stress, inflammation, ECM remodeling, non-coding RNA, and fibroblast/epithelial cell plasticity in BPD.
- Concerns regarding the validity of experimental animal models for BPD are discussed.
- New in vitro models show promise for studying BPD-related lung alveolarization defects.
Conclusions:
- Continued research into BPD pathomechanisms is crucial for improving outcomes in preterm infants.
- Advancements in both in vivo and in vitro modeling are essential for future BPD research and therapeutic development.
More Related Videos
06:15Evaluating Virulence and Pathogenesis of Aeromonas Infection in a Caenorhabditis elegans Model
Published on: December 20, 2018
09:00Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
Published on: August 16, 2024
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Extraction: Advanced Methods